Abstract:METHODS: HepG2/mdr1 was obtained by cloning the whole gene mdr1 into HepG2 cells. shRNA targeting sequence was designed to be homologous to the P-gp encoding MDR1 mRNA consensus sequence. pSUPER-shRNA/mdr1 was constructed using the enzyme-digested technique. HepG2/mdr1 cells were transfected with vectors of pSUPER-shRNA/mdr1 to measure their efficacy by real-time PCR for mdr1 mRNA, flow cytometry (FCM) for P-gp expression, and Rhodamine efflux, MTT method for HepG2/mdr1 function, respectively. In vivo, mice tumors were treated by injecting pSUPER-shRNA/mdr1 in situ and into intraabdominal cavity. Tumors were collected to create cell suspension and cryosections after chemothearpy with adiramycin and mytomycin. The cell suspension was incubated in RPMI-1640 supplemented with G418 to screen stable cells for appreciating the reversal of MDR. Cryosections were treated with immunohistochemistry technique to show the effectiveness of transfection the expression of P-gp.RESULTS: pSUPER-shRNA/mdr1 was successfully constructed, which was confirmed by sequencing. The MDR phenotype of HepG2/mdr1 was decreased significantly in vitro transfection. HepG2/mdr1 showing its MDR was reversed notably in P-gp expression (11.0% vs 98.2%, P < 0.01). Real-time PCR showed that mRNA/mdr1 was lower in test groups than in control groups (18.73 +/- 1.33 vs 68.03 +/- 2.21, P < 0.001). Compared with HepG2, the sensitivity of HepG2/mdr1 and HepG2/mdr1-dsRNA cells to ADM was decreased by 1.64 times and 15.6 times, respectively. The accumulation of DNR in positive groups was decreased evidently. In vivo, the p-gp expression in positive groups was significantly lower than that in control groups (65.1% vs 94.1%, P < 0.05). The tumor suppressing rate in test groups was 57.8%. After chemotherapy, the growth rate in test groups was lower than that in control groups (700.14 +/- 35.61 vs 1659.70 +/- 152.54, P < 0.05). Similar results were also observed under fluorescence microscope, and confirmed by Image-Pro Plus 4.5 analysis.CONCLUSION: pSUPER-ShRNA/mdr1 vector system allows simple, stable and durable nonviral knockdown of P-gp by RNAi in malignant cells and animals to restore their sensitivity to adriamycin. (C) 2009 The WJG Press and Baishideng. All rights reserved.

Suppression of Mrp1 Expression and Restoration of Sensitivity to Chemotherapy in Multidrug-Resistant Hepatocellular Carcinoma Cell Lines HepG2/mrp1 by RNA Interference in Vitro

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

Screening effective sequences of small interfering RNAs targeting mrp1 gene in human HepG2/mrp1 cells

Mechanism underlying drug resistance of HepG2/ADM cells silently reversed by lentivirus-mediated BC047440 gene during chemotherapy

In Vitro And In Vivo Inhibition Of Mrp Gene Expression And Reversal Of Multidrug Resistance By Sirna

RNAi-based knockdown of multidrug resistance-associated protein 1 is sufficient to reverse multidrug resistance of human lung cells.

Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1

Inhibition of MDR1 Expression in Hepatocellular Carcinoma Cell Bel-7402/R by Vector-Mediated RNA Interference

Study On Rna Interference Reversing Multidrug Resistance In K562/A02 Resistant Leukemia Cell.

[Reversal of Multi-Drug Resistance in K562/A02 Cells by Small Interference RNA of Mdr1 Gene].

Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.

shRNA-mediated construction of RNAi expression plasmid and its inhibitory effect on MDR1 expression in hepatocellular carcinoma cell SMMC-7721/R

[Reversal of the Multidrug Resistance in Human Hepatocellular Carcinoma Cells by Recombinant Adenoviral Delivery of the MRP Antisense RNA in Vitro].

Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference

Construction of Expressing Vector of Psuper-Shrna/mrp1 and Its Expression in Vitro

Reversal of Multidrug Resistance in Human Drug-Resistant Hepatocellular Carcinoma Cells by Recombinant Adenoviral Delivery of the Multidrug Resistance-Associated Protein Antisense RNA

[Study on RNA Interference Reversing the Multidrug Resistance of Leukemia Cell].

Reversal of Multi-Drug Resistance by Psuper-Shrna-mdr1 in Vivo and in Vitro.

Co-Suppression Of Mdr1 (Multidrug Resistence 1) And Gcs (Glucosylceramide Synthase) Restores Sensitivity To Mutidrug Resistance Breast Cancer Cells By Rna Interference (Rnai)

siRNAs silence expression of mdr1 gene and its role in reversing drug-resistance in K562/ADM cells

[Reversing Multidrug Resistance in Breast Cancer Cell Line MCF-7/ADR by Small Interfering RNA].